Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH

PURPOSE: A proportion of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) do not achieve treatment goals or experience side effects on their current therapy. In such cases, switching patients to a new drug while discontinuing the first may...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Lung
Autores principales: Gall, Henning, Vachiéry, Jean-Luc, Tanabe, Nobuhiro, Halank, Michael, Orozco-Levi, Mauricio, Mielniczuk, Lisa, Chang, MiKyung, Vogtländer, Kai, Grünig, Ekkehard
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer US 2018
Materias:
Pulmonary Hypertension
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5942346/
https://ncbi.nlm.nih.gov/pubmed/29470642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00408-018-0100-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares